-
1998
Company Description
NovImmmune develops therapeutic monoclonal antibodies to treat patients suffering from immune-related disorders.
NovImmmune is committed to innovation by discovering and developing therapeutic monoclonal antibodies (mAbs) to treat patients suffering from immune-related disorders.
-
Manufacturer:
Science and Engineering -
Formed:
1998 -
Company Website:
-
Company E-mail:
-
Company Address:
14 Chemin des Aulx, 1228 Plan-Les-OuatesGenevaSwitzerland -
We recognize our sponsors starting at $1 per entry.
Learn more at https://www.ithistory.org/benefits